Premenstrual Syndrome Clinical Trial
Official title:
A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine When Used for the Treatment of Premenstrual Dysphoria
The objective of this study is to explore the onset of action when serotonin reuptake inhibitors are used to treat premenstrual dysphoric disorder
Status | Completed |
Enrollment | 24 |
Est. completion date | November 2002 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - The patient should have participated in an ongoing placebo-controlled trial regarding the effect of paroxetine in PMD; to be included in that trial, she must have fulfilled the diagnostic criteria A-C of PMDD in DSM-IV and certain other inclusion and exclusion criteria which are listed in appendix 1. - The patient should a) have been given paroxetine during the previous trial, b) have reported that she has been "much improved" or "very much improved" by this treatment, c) have displayed a marked reduction in VAS-rated irritability during treatment, and d) have reported that she has found the side-effects tolerable. - The patient should display at least a 50% increase in VAS-rated irritability during the luteal phase (mean of last five days prior to menses) as compared the follicular phase (days 6-10) during one cycle of pretreatment symptom rating (without medication). - The patient should have given written informed consent to participate in the study. Exclusion Criteria: - Any concomitant psychiatric disorder for which SRIs are known to be effective. - Any other concomitant psychiatric disorder that, in the investigator's opinion, would render the patient unsuitable for the study. - Any somatic disorder that, in the investigator's opinion, would render the patient unsuitable for the study. - Any ongoing medication which, in the opinion of the investigator, would render the patient unsuitable for the study. Examples of medications that preclude participation in the study are: 1) any psychotropic drug, with the exception of the occasional use of hypnotics, 2) any hormonal preparation, with the exception of thyroid hormone, 3) anti-coagulants, and 4) 5HT1D agonists. Occasional use of analgesic compounds does not preclude participation. - Patient characteristics which, in the opinion of the investigator, are likely to reduce compliance with the protocol. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | The Psychiatric clinic, Sahlgrenska University Hospital | Göteborg |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet | GlaxoSmithKline, Göteborg University, Novo Nordisk A/S |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of patients reaching sustained remission (irritability) for each time point | |||
Secondary | Self rated irritability at each time point |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02481973 -
The Effect of Individualised Homoeopathic Treatment Using the Grant Bentley Method in Premenstrual Syndrome
|
Phase 2 | |
Completed |
NCT00195559 -
Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder
|
Phase 3 | |
Completed |
NCT00048854 -
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
|
Phase 1/Phase 2 | |
Completed |
NCT00965562 -
Comparison of Fluoxetine, Calcium and Placebo for the Treatment of Moderate to Severe Premenstrual Syndrome (PMS)
|
N/A | |
Completed |
NCT05349344 -
Effect of Aerobic Exercise on Premenstrual Syndrome Symptoms (PMS).
|
N/A | |
Recruiting |
NCT06146673 -
A Multidimensional Study of Premenstrual Syndrome and Body Image
|
||
Recruiting |
NCT05836454 -
The Soft Tissue Mobilization Techniques on PMS
|
N/A | |
Completed |
NCT05499000 -
The Effect of Emotional Freedom Technique on Premenstrual Syndrome
|
N/A | |
Recruiting |
NCT06144073 -
The Effect of Mandala Art Therapy in Coping With Premenstrual Syndrome
|
N/A | |
Recruiting |
NCT06105567 -
The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress
|
N/A | |
Completed |
NCT03298607 -
The Impact of Serelys PMS on Symptoms of PMS
|
Phase 3 | |
Recruiting |
NCT06176313 -
Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
|
N/A | |
Recruiting |
NCT02562053 -
Does Adding Oral Contraceptives to Fluoxetine Improve the Management of Premenstrual Syndrome?
|
Phase 3 | |
Completed |
NCT00229346 -
Fibromyalgia and Psychiatric Symptoms Among PMS and PMDD Patients
|
N/A | |
Completed |
NCT04901598 -
Physical Activity Level, Aerobic Capacity and Dietary Habits Among a Cohort of Females With Premenstrual Syndrome
|
||
Completed |
NCT05692479 -
Premenstrual Syndrome and Physical Activity Self-Worth
|
||
Completed |
NCT05665972 -
Effects of Mandala Coloring on Premenstrual Syndrome
|
N/A | |
Not yet recruiting |
NCT06052722 -
The Relationship of Premenstrual Syndrome and Primary Dysmenorrhea With Severity of Temporomandibular Disorders
|
N/A | |
Completed |
NCT05556252 -
The Effect of Hydrogen-rich Water on Premenstrual Symptoms and Quality of Life
|
N/A | |
Completed |
NCT05725447 -
Cross-cultural Adaptation, Validity and Reliability of the Turkish Version of the Premenstrual Syndrome Impact Questionnaire (PMS-IQ)
|